Quantcast

Silver State Times

Friday, November 15, 2024

FDA conducted second lowest number of inspections on Drugs companies in Nevada during Q1 2023

Webp wpqolpnrcij8e8mt9jfg90exrory

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

Mark Raza Principal Deputy Chief Counsel - FDA | Official Website

In the first quarter of 2023, two Drugs companies received two FDA inspections in Nevada, according to the U.S. Food and Drug Administration (FDA).

This was the second lowest number of inspections per type of company made by the FDA in Nevada, equalling 18.2% of all inspections in the first quarter of 2023.

Of all the Nevada companies involved in the Drugs sector, Kent L. Wellish, M.D. received the most citations from the FDA in the first quarter of 2023.

The FDA routinely inspects facilities across the nation to determine if the workplaces and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly for businesses to consistently make smarter business decisions for the future.

The FDA is a government agency primarily responsible for monitoring the manufacturing and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality, according to its website.

FDA Inspections in Nevada During Q1 2023
Project AreaNo Action IndicatedVoluntary Action IndicatedOfficial Action Indicated
Bioresearch Monitoring11--
Blood and Blood Products5----
Compliance: Devices1----
Foodborne Biological Hazards3----
Human Cellular, Tissue, and Gene Therapies--1--
Technical Assistance: Food and Cosmetics3----
Vaccines and Allergenic Products5----

ORGANIZATIONS IN THIS STORY

!RECEIVE ALERTS

The next time we write about any of these orgs, we’ll email you a link to the story. You may edit your settings or unsubscribe at any time.
Sign-up

DONATE

Help support the Metric Media Foundation's mission to restore community based news.
Donate

MORE NEWS